Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Best Peptides for Sprained Ankle: Comparison

This table compares the primary research-grade peptides used in soft tissue injury recovery, focusing on mechanism, administration, and practical application for ankle sprains. BPC-157 Sustains VEGF and TGF-β signaling through proliferative phase; promotes ang

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • This table compares the primary research-grade peptides used in soft tissue injury recovery, focusing on mechanism, administration, and practical application for ankle sprains.
  • BPC-157
  • Sustains VEGF and TGF-β signaling through proliferative phase; promotes angiogenesis and collagen synthesis
  • 250–500 mcg SC 1–2x daily for 2–4 weeks
  • Days 3–21 (proliferative phase)
  • Most research-supported for ligament-specific healing; works best when started after acute inflammation peaks
  • TB-500
  • Upregulates G-actin to enhance cell migration; reduces IL-6 and TNF-α expression during acute inflammation
  • 2–2.5 mg SC 2–3x weekly for 2 weeks, then 1x weekly
  • First 72 hours through day 14 (inflammation + early proliferation)
  • Critical for reducing fibrosis; efficacy drops if not administered within 5 days of injury
  • GHK-Cu
  • Copper-dependent collagen remodeling; modulates MMP (matrix metalloproteinase) activity
  • 1–2 mg SC daily for 3–4 weeks
  • Days 7–28 (remodeling phase)
  • Weaker evidence base for acute ligament injuries; better suited for chronic tendinopathy
  • Ipamorelin
  • Stimulates growth hormone release; indirect collagen synthesis support
  • 200–300 mcg SC before bed, 5 days/week
  • Entire recovery timeline (adjunct only)
  • Does not target injury-specific pathways; useful for systemic recovery but not ligament-specific repair
  • Epitalon
  • Telomerase activation; cellular senescence reduction
  • 5–10 mg SC for 10–20 days
  • Post-recovery maintenance (not acute injury)
  • No direct mechanism for acute soft tissue healing; belongs in longevity protocols, not injury recovery